Drug shows promise in halting rare body overgrowth disorder
NCT ID NCT02443818
First seen Nov 21, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tested a drug called sirolimus in 16 people with a rare condition causing parts of their body to grow too much due to a PIK3CA gene change. The goal was to see if sirolimus could stop or slow this overgrowth. Participants took the drug and were monitored with scans and measurements to track changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEGMENTAL OVERGROWTH DISORDERS DUE TO PIK3CA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU de Montpellier - Hôpital Saint-Eloi
Montpellier, 34295, France
-
CHRU de Tours
Tours, 37044, France
-
CHU Paris - Necker
Paris, 75015, France
-
CHU d'Angers
Angers, 49933, France
-
CHU de Bordeaux - GH Pellegrin
Bordeaux, 33076, France
-
CHU de DIJON
Dijon, 21079, France
-
HCL Lyon - CH Lyon Sud
Pierre-Bénite, 69495, France
-
Hopitaux de Brabois Chu Nancy
Nancy, 54511, France
-
Hôpital Jeanne de Flandre
Lille, 59037, France
-
Hôpital mère-enfant de Nantes
Nantes, 44093, France
-
Pôle Cardiovasculaire et Métabolique - Hôpital Larrey
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.